These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26772398)

  • 1. Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24-/low) indicate poor prognosis in triple-negative breast cancer.
    Chang SJ; Ou-Yang F; Tu HP; Lin CH; Huang SH; Kostoro J; Hou MF; Chai CY; Kwan AL
    Hum Pathol; 2016 Feb; 48():48-55. PubMed ID: 26772398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
    Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
    Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
    Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
    Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer.
    Zou W; Yang Y; Zheng R; Wang Z; Zeng H; Chen Z; Yang F; Wang J
    Int J Clin Exp Pathol; 2020; 13(5):1008-1016. PubMed ID: 32509072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cancer stem cell markers in basal and penta-negative breast carcinomas--a study of a series of triple-negative tumors.
    Uchôa Dde M; Graudenz MS; Callegari-Jacques SM; Hartmann CR; Ferreira BP; Fitarelli-Kiehl M; Edelweiss MI
    Pathol Res Pract; 2014 Jul; 210(7):432-9. PubMed ID: 24726267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of human breast cancer CD44
    Qiao X; Zhang Y; Sun L; Ma Q; Yang J; Ai L; Xue J; Chen G; Zhang H; Ji C; Gu X; Lei H; Yang Y; Liu C
    Elife; 2021 Jul; 10():. PubMed ID: 34318746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
    Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
    Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).
    Ma F; Li H; Wang H; Shi X; Fan Y; Ding X; Lin C; Zhan Q; Qian H; Xu B
    Cancer Lett; 2014 Oct; 353(2):153-9. PubMed ID: 25130168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44
    Abdoli Shadbad M; Hosseinkhani N; Asadzadeh Z; Derakhshani A; Karim Ahangar N; Hemmat N; Lotfinejad P; Brunetti O; Silvestris N; Baradaran B
    Front Oncol; 2021; 11():689839. PubMed ID: 34434894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44
    Wang H; Wang L; Song Y; Wang S; Huang X; Xuan Q; Kang X; Zhang Q
    Oncol Lett; 2017 Nov; 14(5):5890-5898. PubMed ID: 29113223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
    Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
    Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer.
    Collina F; Di Bonito M; Li Bergolis V; De Laurentiis M; Vitagliano C; Cerrone M; Nuzzo F; Cantile M; Botti G
    Biomed Res Int; 2015; 2015():158682. PubMed ID: 26504780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD44 as cancer stem cell marker in triple-negative breast cancer and its association with histological grade and angiogenesis.
    Tomar R; Rakheja G; Verma N; Thakur S; Khurana N; Ghuliani D
    Indian J Pathol Microbiol; 2023; 66(2):258-263. PubMed ID: 37077065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.
    O'Conor CJ; Chen T; González I; Cao D; Peng Y
    Biomark Med; 2018 Jul; 12(7):813-820. PubMed ID: 29902924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
    Giatromanolaki A; Sivridis E; Fiska A; Koukourakis MI
    Med Oncol; 2011 Sep; 28(3):745-52. PubMed ID: 20405247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
    Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
    Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.